Pharmacogenetics guidelines: overview and comparison of the DPWG, CPIC, CPNDS, and RNPGx guidelines

H Abdullah-Koolmees, AM Van Keulen… - Frontiers in …, 2021 - frontiersin.org
Many studies have shown that the efficacy and risk of side effects of drug treatment is
influenced by genetic variants. Evidence based guidelines are essential for implementing …

The clinical pharmacogenetics implementation consortium: 10 years later

MV Relling, TE Klein, RS Gammal… - Clinical …, 2020 - Wiley Online Library
In 2009, the Clinical Pharmacogenetics Implementation Consortium (CPIC, www. cpicpgx.
org), a shared project between Pharmacogenomics Knowledge Base (PharmGKB …

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data

Y Zhou, VM Lauschke - The Pharmacogenomics Journal, 2022 - nature.com
Genes encoding cytochrome P450 enzymes (CYPs) are extremely polymorphic and multiple
CYP variants constitute clinically relevant biomarkers for the guidance of drug selection and …

[HTML][HTML] A case study on decentralized manufacturing of 3D printed medicines

I Seoane-Viano, X Xu, JJ Ong, A Teyeb… - International Journal of …, 2023 - Elsevier
Abstract Pharmaceutical 3D printing (3DP) is one of the emerging enabling technologies of
personalised medicines as it affords the ability to fabricate highly versatile dosage forms. In …

CYP2B6 functional variability in drug metabolism and exposure across populations—implication for drug safety, dosing, and individualized therapy

IM Langmia, KS Just, S Yamoune, J Brockmöller… - Frontiers in …, 2021 - frontiersin.org
Adverse drug reactions (ADRs) are one of the major causes of morbidity and mortality
worldwide. It is well-known that individual genetic make-up is one of the causative factors of …

Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank

B Li, K Sangkuhl, R Whaley, M Woon, K Keat… - The American Journal of …, 2023 - cell.com
Pharmacogenomics (PGx) is an integral part of precision medicine and contributes to the
maximization of drug efficacy and reduction of adverse drug event risk. Accurate information …

PharmVar GeneFocus: CYP2B6

Z Desta, A El‐Boraie, L Gong… - Clinical …, 2021 - Wiley Online Library
The Pharmacogene Variation Consortium (PharmVar) catalogs star (*) allele nomenclature
for the polymorphic human CYP2B6 gene. Genetic variation within the CYP2B6 gene locus …

Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs

OA Badary - The pharmacogenomics journal, 2021 - nature.com
The outbreak of Coronavirus disease 2019 (COVID-19) has evolved into an emergent global
pandemic. Many drugs without established efficacy are being used to treat COVID-19 …

Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease

NR Powell, T Liang, J Ipe, S Cao, TC Skaar… - Nature …, 2023 - nature.com
Polypharmacy is common in patients with nonalcoholic fatty liver disease (NAFLD) and
previous reports suggest that NAFLD is associated with altered drug disposition. This study …

A population study of clinically actionable genetic variation affecting drug response from the Middle East

PV Jithesh, M Abuhaliqa, N Syed, I Ahmed… - NPJ genomic …, 2022 - nature.com
Clinical implementation of pharmacogenomics will help in personalizing drug prescriptions
and alleviate the personal and financial burden due to inefficacy and adverse reactions to …